Jonas Grossman - 09 Mar 2023 Form 4 Insider Report for Monterey Innovation Acquisition Corp

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Mar 2023, 21:57:43 UTC
Prior SEC filing
05 Dec 2022
Next SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason T. Simon, as Attorney-in-Fact

Key filing fact

Jonas Grossman filed Form 4 for Monterey Innovation Acquisition Corp on 13 Mar 2023.

Key facts

  • This page summarizes Jonas Grossman's Form 4 filing for Monterey Innovation Acquisition Corp.
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Mar 2023, 21:57.

Change

  • Previous filing in this sequence was filed on 05 Dec 2022.
  • Current net transaction value: +$2,790.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MTRY transaction

Common Stock

Sale

Transaction value
$78.75
Shares
-13,125
Change %
-2.1%
Price
$0.006000*
Shares after
624,375
Date
09 Mar 2023
Ownership
By Chardan Monterey Investments LLC
Footnotes
F1, F2
MTRY transaction

Common Stock

Purchase

Transaction value
$2,869
Shares
+478,125
Change %
+77%
Price
$0.006000*
Shares after
1,102,500
Date
09 Mar 2023
Ownership
By Chardan Monterey Investments LLC
Footnotes
F2, F3
MTRY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
35,000
Date
09 Mar 2023
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares of common stock transferred from Chardan Monterey Investments LLC ("Chardan") to certain affiliates of Chardan for a price per share of $0.006, pursuant to Share Transfer Agreements dated March 9, 2023.

Footnote F2

The shares are held directly by Chardan. The Reporting Person is the managing member of Chardan. Accordingly, the Reporting Person has voting and dispositive power over the shares held by Chardan and may be deemed to beneficially own such shares. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Footnote F3

Represents shares of common stock transferred from NorthStar Bio Ventures, LLC ("NorthStar") to Chardan for a price per share of $0.006, pursuant to a Share Transfer Agreement dated March 9, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .